Descriptive Analysis of Changes in Hepatitis B Markers in People Living With HIV on Injectable Therapy.

A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B

NCT01264133 ·Status: TERMINATED ·Phase: PHASE4

Application of HBV Rapid Tests as a Tool for Wide-Use Screening

NCT01767597 ·Status: COMPLETED ·Phase: NA

Study for Consolidation Period of Chronic Hepatitis B

NCT01732354 ·Status: COMPLETED

Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine

NCT00640588 ·Status: COMPLETED ·Phase: PHASE3

Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis B

NCT01270165 ·Status: UNKNOWN ·Phase: PHASE3

Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV

NCT00051090 ·Status: WITHDRAWN ·Phase: NA

Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C Infection

NCT03248622 ·Status: COMPLETED

Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNA

NCT00625339 ·Status: COMPLETED ·Phase: PHASE4

Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients

NCT01356901 ·Status: COMPLETED

Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies

NCT00142298 ·Status: COMPLETED ·Phase: PHASE3

Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infection

NCT01273142 ·Status: UNKNOWN

ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy

NCT00823342 ·Status: TERMINATED ·Phase: PHASE3

Study of Telbivudine in Chronic Hepatitis B

NCT00970216 ·Status: COMPLETED

Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks

NCT00862706 ·Status: WITHDRAWN ·Phase: PHASE4

Immunogenicity and Persistence of Hepatitis B Vaccination in HIV-Infected Patients

NCT03962803 ·Status: UNKNOWN ·Phase: PHASE4

Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With Telbivudine

NCT01005238 ·Status: TERMINATED ·Phase: PHASE4

Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.

NCT00158717 ·Status: COMPLETED

Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B

NCT00115245 ·Status: COMPLETED ·Phase: PHASE3

Efficacy Study of Telbivudine in Chronic Hepatitis B Patients

NCT01958229 ·Status: COMPLETED

Long-term Study With Clevudine

NCT00558818 ·Status: COMPLETED ·Phase: PHASE4

Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B

NCT00132652 ·Status: COMPLETED ·Phase: PHASE3

An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B

NCT00467545 ·Status: COMPLETED ·Phase: PHASE4

Terminator 2 Register

NCT03643172 ·Status: UNKNOWN

Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B

NCT01743079 ·Status: COMPLETED ·Phase: PHASE4

Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral Agents

NCT02337127 ·Status: UNKNOWN ·Phase: PHASE4